Document is current

Article History

Received: 22 January 2026

Accepted: 16 July 2026

First Online: 22 August 2026

Declarations

Conflict of Interest: Dawn A. Laney is a member of the North American Fabry Registry Board, consults and/or has been an investigator and/or coordinator in clinical trials sponsored by Amicus Therapeutics, Chiesi Farmaceutici, Sangamo, Sanofi-Genzyme, and Takeda-Shire. These activities have been monitored and found to be in compliance with the conflict-of-interest policies at the Emory University School of Medicine. Suma P. Shankar is Albert Rowe endowed chair in Genetics and receives salary and research support. The authors report no other conflicts of interest in this work. Madelena M. Martin has nothing to disclose. Ayaka Suzuki has nothing to disclose. Siddarth V. Shankar has nothing to disclose.

Ethical Approval: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.